Amicus Therapeutics, Inc. · Cranbury, NJ United States ·(NASDAQ (GM): FOLD)
Company Description
View Amicus Therapeutics, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Amicus Therapeutics develops drugs that treat rare genetic diseases known as lysosomal storage disorders. The company's enzyme replacement therapies are designed to target defective proteins and restore their functions. Its lead drug candidate, Amigal, is aimed at aiding patients with Fabry disease, whose symptoms include skin rashes, impaired sweating, and gastrointestinal, heart, and kidney problems that vary in severity. Amicus is also developing drugs to treat Gaucher disease, a disorder that can cause anemia and skeletal lesions, and Pompe disease, which causes muscle weakness and impairs breathing, mobility, and heart function. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Amicus Therapeutics, Inc. Financials
| Company Type | Public - NASDAQ (GM): FOLD Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $15.0 |
| 2007 Employees | 115 |
Amicus Therapeutics, Inc. Executives
18 executives listed for Amicus Therapeutics, Inc.'s Cranbury, NJ location.
| Title | Name & Bio | Contact |
| Chairman | Donald Hayden | Network |
| President, CEO, and Director | John Crowley | Network |
| COO | Matthew Patterson | Network |
Competition
Competitive Landscape for Amicus Therapeutics, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Amicus Therapeutics, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!